eNewsroom for: Regenexx

http://pressreleaseheadlines.com/wp-content/Cimy_User_Extra_Fields/Regenexx/Screen Shot 2013-04-08 at 6.22.33 PM.png

Regenexx Company Profile

The Centeno-Schultz Clinic is a research-based medical practice founded by Christopher J. Centeno, M.D., and John R. Schultz, M.D. The Regenexx-C procedure has been studied extensively for several years and continues to prove to be safe and reliable. We maintain what we believe to be the world’s largest human mesenchymal stem cell re-implantation database for orthopedic purposes. This procedure was first used as part of an IRB supervised clinical trial from 2005-2007. During this time our medical practice invested hundreds of thousands of dollars in providing investigational care with all patients receiving before and after research grade MRI’s. For more information on how physicians innovate versus how FDA/drug companies discover new drugs, see this link. By late 2007, once the physicians were satisfied that the procedure was working and that the complications were less than existing surgical care, the clinic began treating patients. Since that time the clinic has published many medical research papers listed in the U.S. Library of Medicine (see this link for an incomplete list). Every patient treated by us is entered into a treatment registry and will be contacted at various time points regarding the outcome of the procedure, any complications, etc… As a result, we have extensive experience in what works and what doesn’t work. In addition, based on our published complications papers, our procedure produces significantly fewer complications than the more invasive surgical procedures it helps many patients avoid. In addition to peer reviewed publications, we also publish our registry data on-line. See data on Regenexx-SD and the Regenexx-PL-Disc procedures. [Disclaimer: The Regenexx same day procedures (-SD, -AD, -SCP, -PL-Disc, etc...) are preformed in the United States. The Regenexx-C cultured stem cell procedure is only offered through RegenexxCayman, which is an independently owned and operated medical services provider operating exclusively in the Cayman Islands and is not part of or affiliated with the Centeno-Schultz Clinic or any U.S. Regenexx Network provider. The Regenexx-C procedure licensed by RegenexxCayman is not approved by the U.S. FDA for use in the United States.]

News from Regenexx:

Regenexx Publishes the World's Largest Stem Cell Safety Paper

DENVER, June 15, 2016 /PRNewswire/ — Regenexx, a Colorado-based, national interventional orthopedics medical group, recently published the world's largest stem cell safety paper. The study was published in International Orthopaedics (March 30, 2016). The purpose of the study was to determine if mesenchymal-stem-cell-based therapies are safe procedures when used for orthopedic degenerative conditions or injuries, […]

Dr. Centeno to Speak on Stem Cells for Treating Orthopedic Injuries at NFL Scouting Combine

INDIANAPOLIS, Feb. 25, 2016 /PRNewswire/ — Dr. Christopher Centeno, CEO of Regenexx® and international expert and researcher in the field of stem cells in orthopedics, will address NFL physicians on the topic "Stem Cells: What's Real and What's Hype" at the 2016 NFL Scouting Combine, where NFL teams evaluate the nation's top college football players eligible […]

Regenexx® Announces Issue of United States Patent on Proprietary Orthopedic Stem Cell Procedure

DENVER, Oct. 28, 2015 /PRNewswire/ — Regenexx® today announced the recent issue of a US Patent on their proprietary same day stem cell procedure used to treat joint injuries, spine pain and degenerative orthopedic conditions, such as osteoarthritis. This patent continues to add to the company's expanding intellectual (IP) property portfolio. Logo – http://photos.prnewswire.com/prnh/20151027/281221LOGO To review […]

Regenexx® Announces Positive Results From Largest Knee Osteoarthritis Stem Cell Treatment Study to Date

DENVER, Sept. 9, 2015 /PRNewswire/ — Regenexx®, a nationwide network of doctors specializing in regenerative medicine and advanced interventional orthopedic techniques, today announced the results of a peer-reviewed research study of 840 patients treated for knee osteoarthritis. All patients were treated using precise imaging guidance and the patented Regenexx protocol, which obtains stem cells from […]

As Concern about Steroid Epidurals Increases, New Registry Data Suggests Growth Factors From Blood Platelets Might Work Better

BROOMFIELD, Colo., April 9, 2013 /PRNewswire/ — Dr. Christopher Centeno, founder of the Regenexx family of regenerative orthopedic procedures used to help patients avoid more invasive orthopedic surgery, announced today the positive results of a comparison between traditional steroid epidural injections and injections that use natural growth factors isolated from the patient's own blood. Steroid epidurals […]